GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (LSE:IXI) » Definitions » Float Percentage Of Total Shares Outstanding

IXICO (LSE:IXI) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 16, 2024)


View and export this data going back to 1996. Start your Free Trial

What is IXICO Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IXICO's float shares is 0.00 Mil. IXICO's total shares outstanding is 48.35 Mil. IXICO's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IXICO's Insider Ownership is 9.31%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IXICO's Institutional Ownership is 6.67%.

IXICO Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

IXICO's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/48.35
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO (LSE:IXI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (LSE:IXI) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
LSE:APTA LSE:VAL LSE:OCTP LSE:FAB LSE:TCF LSE:BSFA LSE:ROQ LSE:GENF LSE:PYC LSE:CIZ OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
PHYOF:USA
Address
15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
Website
https://www.ixico.com
IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

IXICO (LSE:IXI) Headlines

No Headlines